Limula
Limula is building a smart automation solution for the production of the most complex, most expensive, but also most personalized cancer treatment ever invented.
Vaud, Switzerlandlimula.ch ↗
Total raised
€6.5M
€6,498,801
Funding rounds
4
Investors
9
distinct backers
Active since
2022-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood36
base rate 44% for Seed
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood14
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| — | Other | — | — | View deal → |
| 2024-05-21 | Seed | €6.3M | Angel Investors,Lichtsteiner Foundation,LifeX Ventures,Oxford Seed Fund,Verve Ventures,W.A. de Vigier Foundation+1 more | View deal → |
| 2023-10-16 | Other | €237k | BioTools Innovator | View deal → |
| 2022-10-11 | Other | — | Biopôle Start-up Fund | View deal → |
Investors
9Related news
- Biopôle Funding for Limula and ND Biosciencesstartupticker.ch · 2022-10
- tech.eu
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy